机构

• 上海药物研究所 [7]
• 上海营养与健康研究所 [3]
• 成都生物研究所 [2]
• 昆明植物研究所 [1]
• 自动化研究所 [1]

采集方式

• OAI收割 [14]

内容类型

• 期刊论文 [13]
• 学位论文 [1]

发表日期

• 2024 [1]
• 2022 [1]
• 2020 [1]
• 2019 [3]
• 2018 [3]
• 2014 [2]
• 更多

学科主题

• Biochemist... [1]
• Endocrinol... [1]
• Life Scien... [1]
• Plant Scie... [1]
• 药物化学 [1]

筛选

浏览/检索结果: 共14条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Lindenane sesquiterpenoid dimers from Chloranthus japonicus improve LDL uptake by regulating PCSK9 and LDLR 期刊论文  OAI收割 BIOORGANIC CHEMISTRY, 2024, 卷号: 142, 页码: 13 作者:  Guo, Pengju;  Chen, Tong;  Hu, Xianggang;  Duan, Yelin;  Zheng, Liu   |  收藏  |  浏览/下载：24/0  |  提交时间：2024/01/16 Chloranthus japonicas  Lindenane sesquiterpenoid dimers  PCSK9  LDLR   Fused-ring alpha-pyrones from intramolecular C-H activation and their lipids-lowering activity associated with LXR-IDOL-LDLR axis regulation 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 244, 页码: 11 作者:  Mao, Yingle;  Li, Jiaomeng;  Tang, Chunping;  Ma, Biao;  Xu, Zhijian   |  收藏  |  浏览/下载：29/0  |  提交时间：2023/04/10 C-H activation  One-pot intramolecular cyclization  ?-Pyrone derivatives  LDL uptaking  LXR-IDOL-LDLR axis  In vivo lipids-lowering effect   23,24-Dihydrocucurbitacin B promotes lipid clearance by dual transcriptional regulation of LDLR and PCSK9 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2020, 卷号: 41, 期号: 3, 页码: 327-335 作者:  Li, Hui-hui;  Li, Jun;  Zhang, Xian-jing;  Li, Jiao-meng;  Xi, Cong   |  收藏  |  浏览/下载：37/0  |  提交时间：2020/07/01 23,24-dihydrocucurbitacin B  lipid-lowering agent  LDLR  PCSK9  HNF1 alpha  SREBP2   designsynthesisandbiologicalevaluationofnoveltetrahydroprotoberberinederivativesthpbsasproproteinconvertasesubtilisinkexintype9pcsk9modulatorsforthetreatmentofhyperlipidemia 期刊论文  OAI收割 actapharmaceuticasinicab, 2019, 卷号: 9, 期号: 6, 页码: 1216 作者:  Wu Chenglin;  Xi Cong;  Tong Junhua;  Zhao Jing;  Jiang Hualiang   |  收藏  |  浏览/下载：11/0  |  提交时间：2020/07/01 DOPAMINE D-1  BERBERINE  EXPRESSION  INHIBITORS  IDENTIFICATION  CHOLESTEROL  MUTATIONS  LDLR  PCSK9  Tetrahydroprotoberberine derivatives  Low-density lipoprotein cholesterol  Lipid-lowering  PCSK9 expression  Low-density lipoprotein receptor  Total cholesterol  Hyperlipidemia hamster   Endogenous cholesterol ester hydroperoxides modulate cholesterol levels and inhibit cholesterol uptake in hepatocytes and macrophages 期刊论文  OAI收割 REDOX BIOLOGY, 2019, 卷号: 21, 期号: -, 页码: UNSP 101069 作者:  Guo, Shuyuan;  Lu, Jianhong;  Zhuo, Yujuan;  Xiao, Mengqing;  Xue, Xinli   |  收藏  |  浏览/下载：29/0  |  提交时间：2020/12/09 Cholesterol/metabolism  LDL oxidation  Lipidomics  CVD  Cholesterol ester hydroperoxides  Cholesterol uptake  Lipid peroxidation  LXR  LDLR   PAQR3 modulates blood cholesterol level by facilitating interaction between LDLR and PCSK9 期刊论文  OAI收割 METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 卷号: 94, 期号: -, 页码: 88-95 作者:  Huang, Meiqin;  Zhao, Zilong;  Cao, Qianqian;  Wei, Siying;  Zhao, Jingyu   |  收藏  |  浏览/下载：16/0  |  提交时间：2020/12/09 Low-density lipoprotein cholesterol  LDLR  PCSK9  Endosome  Protein degradation   An Innovation for Treating Orthotopic Pancreatic Cancer by Preoperative Screening and Imaging-Guided Surgery 期刊论文  OAI收割 Molecular Imaging And Biology, 2018, 期号: x, 页码: x 作者:  Ziyu Han;  Wenting Shang;  Xiaoyuan Liang;  Hao Yan;  Min Hu   |  收藏  |  浏览/下载：54/0  |  提交时间：2018/10/10 Low-density Lipoprotein Receptor (Ldlr)  Photoacoustic Imaging  Peptide-22  Optical-guided Surgery   Phenolic Compounds from Belamcanda chinensis Seeds 期刊论文  OAI收割 MOLECULES, 2018, 卷号: 23, 期号: 3, 页码: 580 作者:  Song, Ying-Ying;  Liu, Ying;  Yan, Yong-Ming;  Lu, Xi-Feng;  Cheng, Yong-Xian   |  收藏  |  浏览/下载：26/0  |  提交时间：2018/07/02 Belamcanda Chinensis  Belamcanosides a And b  Gc Analysis  Hmgcr  Sqle  Ldlr  Sort1   Chemotherapy drugs induce pyroptosis through caspase-3-dependent cleavage of GSDME 期刊论文  OAI收割 SCIENCE CHINA-LIFE SCIENCES, 2018, 卷号: 61, 期号: 6, 页码: 739-740 作者:  Zhang, Xixi;  Zhang, Haibing;  ,   |  收藏  |  浏览/下载：13/0  |  提交时间：2020/12/09 Low-density lipoprotein cholesterol  LDLR  PCSK9  Endosome  Protein degradation   MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2014, 卷号: 35, 期号: 8, 页码: 994-1004 作者:  Yan, Hong;  Ma, Yan-ling;  Gui, Yu-zhou;  Wang, Shu-mei;  Wang, Xin-bo   |  收藏  |  浏览/下载：31/0  |  提交时间：2019/01/08 cholesterol homeostasis  LDLR  MG132  proteasome inhibition  PKC  PCSK9  pravastatin  HepG2  cells